Increased Donor Age Leads to Greater Severity of Ocular Graft-Versus-Host Disease Following Allogeneic Hematopoietic Stem Cell Transplantation

Jeremy Chang; Lan Y Wang; Gloria B Chiu; Rachel Young; Mojtaba Akhtari

doi:10.1016/j.bbmt.2018.12.245

Increased Donor Age Leads to Greater Severity of Ocular Graft-Versus-Host Disease Following Allogeneic Hematopoietic Stem Cell Transplantation

Jeremy Chang, Lan Y Wang, Gloria B Chiu, Rachel Young, Mojtaba Akhtari

Medicine

Research output: Contribution to journal › Article › peer-review

Original language	American English
Journal	Biology of Blood and Marrow Transplantation
Volume	25
DOIs	https://doi.org/10.1016/j.bbmt.2018.12.245
State	Published - Mar 1 2019

Disciplines

Immunology and Infectious Disease
Internal Medicine
Medicine and Health Sciences

Access to Document

10.1016/j.bbmt.2018.12.245License: Unspecified

OpenUrl availability

Full text

Cite this

@article{3002cf44093e4d7db35684355140ae0d,

title = "Increased Donor Age Leads to Greater Severity of Ocular Graft-Versus-Host Disease Following Allogeneic Hematopoietic Stem Cell Transplantation",

author = "Jeremy Chang and Wang, {Lan Y} and Chiu, {Gloria B} and Rachel Young and Mojtaba Akhtari",

note = "JavaScript is disabled on your browser. Please enable JavaScript to use all the features on this page. Ocular graft-versus-host disease (GVHD) is a common complication of allogeneic hematopoietic stem cell transplantation (HSCT), affecting 40-60% of patients within 3 years after transplant.",

year = "2019",

month = mar,

day = "1",

doi = "10.1016/j.bbmt.2018.12.245",

language = "American English",

volume = "25",

journal = "Biology of Blood and Marrow Transplantation",

}

TY - JOUR

T1 - Increased Donor Age Leads to Greater Severity of Ocular Graft-Versus-Host Disease Following Allogeneic Hematopoietic Stem Cell Transplantation

AU - Chang, Jeremy

AU - Wang, Lan Y

AU - Chiu, Gloria B

AU - Young, Rachel

AU - Akhtari, Mojtaba

N1 - JavaScript is disabled on your browser. Please enable JavaScript to use all the features on this page. Ocular graft-versus-host disease (GVHD) is a common complication of allogeneic hematopoietic stem cell transplantation (HSCT), affecting 40-60% of patients within 3 years after transplant.

PY - 2019/3/1

Y1 - 2019/3/1

UR - https://www.sciencedirect.com/science/article/pii/S108387911831067X

U2 - 10.1016/j.bbmt.2018.12.245

DO - 10.1016/j.bbmt.2018.12.245

M3 - Article

VL - 25

JO - Biology of Blood and Marrow Transplantation

JF - Biology of Blood and Marrow Transplantation

ER -

Increased Donor Age Leads to Greater Severity of Ocular Graft-Versus-Host Disease Following Allogeneic Hematopoietic Stem Cell Transplantation

Disciplines

Access to Document

OpenUrl availability

Other files and links

Cite this